Stocks
AbbVie Inc.ABBV
NYSEHealthcarePharmaceuticals$219.68-2.52%
A large U.S. biopharmaceutical company focused on immunology, oncology, neuroscience, and aesthetics medicines. Its portfolio includes blockbuster drugs such as Skyrizi and Rinvoq, as well as Botox and other aesthetics products acquired through the Allergan deal. Investors closely watch the company ...
Market Cap: $388.4B52W Range: $164.39 – $244.81
Congressional Interest in AbbVie Inc. (ABBV)
22 members of Congress have disclosed 50 trades in AbbVie Inc. (ABBV), a Healthcare company. The buy/sell breakdown shows 28 purchases versus 22 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
22
Buys
28
Sells
22
Who in Congress Is Trading ABBV?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-01-20 | John Hoeven | sell | $100K – $250K |
| 2017-01-20 | Kurt Schrader | buy | $1K – $15K |